(19)
(11) EP 3 989 976 A1

(12)

(43) Date of publication:
04.05.2022 Bulletin 2022/18

(21) Application number: 20832928.4

(22) Date of filing: 25.06.2020
(51) International Patent Classification (IPC): 
A61K 31/519(2006.01)
A61K 45/06(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/506; A61P 43/00
(86) International application number:
PCT/US2020/039674
(87) International publication number:
WO 2020/264201 (30.12.2020 Gazette 2020/53)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 26.06.2019 WO PCT/US2019/039333
20.12.2019 WO PCT/US2019/006795

(71) Applicant: Eisai R&D Management Co., Ltd.
Tokyo 112-8088 (JP)

(72) Inventors:
  • MOLINE, Margaret
    White Plains, NY 10605 (US)
  • KRAMER, Lynn
    Woodcliff Lake, New Jersey 07677 (US)
  • DHADDA, Shobha
    Woodcliff Lake, New Jersey 07677 (US)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)

   


(54) LEMBOREXANT FOR TREATING SLEEP ISSUES